Maternal immunity and prevention of congenital cytomegalovirus infection
- PMID: 12597753
- DOI: 10.1001/jama.289.8.1008
Maternal immunity and prevention of congenital cytomegalovirus infection
Abstract
Context: Vaccine development to prevent congenital cytomegalovirus (CMV) infection has been impeded by the uncertainty over whether maternal immunity protects the fetus.
Objective: To determine whether the presence of maternal antibodies to CMV significantly reduces the risk of congenital CMV infection in future pregnancies.
Design, setting, and participants: Cohort study of 3461 multiparous women from a population with a high rate of congenital CMV infection who delivered newborns screened for congenital CMV infection between 1993 and 1998, and whose cord serum specimen from a previous delivery could be retrieved and tested for antibody to CMV.
Main outcome measure: Congenital CMV infection according to maternal immune status, age, race, parity, and socioeconomic status.
Results: Of 604 newborns born to initially seronegative mothers, congenital CMV infection occurred in 18 (3.0%). In contrast, of 2857 newborns born to immune mothers, congenital CMV infection occurred in 29 (1.0%) Two factors, preconception maternal immunity (adjusted risk ratio, 0.31; 95% confidence interval, 0.17-0.58) and maternal age of 25 years or older (adjusted risk ratio, 0.19; 95% confidence interval, 0.07-0.49), were highly protective against congenital CMV infection. No other factors were associated with a reduction in the risk of congenital CMV infection.
Conclusion: Naturally acquired immunity results in a 69% reduction in the risk of congenital CMV infection in future pregnancies.
Comment in
-
Natural vs vaccine-acquired immunity to cytomegalovirus.JAMA. 2003 Oct 1;290(13):1709; author reply 1709. doi: 10.1001/jama.290.13.1709-a. JAMA. 2003. PMID: 14519704 No abstract available.
Similar articles
-
CMV seroconversion in pregnants and the incidence of congenital CMV infection.Turk J Pediatr. 2007 Jan-Mar;49(1):30-6. Turk J Pediatr. 2007. PMID: 17479641
-
Cytomegalovirus (CMV) glycoprotein H-based serological analysis in Japanese healthy pregnant women, and in neonates with congenital CMV infection and their mothers.J Clin Virol. 2013 Oct;58(2):474-8. doi: 10.1016/j.jcv.2013.07.004. Epub 2013 Aug 1. J Clin Virol. 2013. PMID: 23916379
-
Strong Cell-Mediated Immune Response to Human Cytomegalovirus Is Associated With Increased Risk of Fetal Infection in Primarily Infected Pregnant Women.Clin Infect Dis. 2015 Oct 15;61(8):1228-34. doi: 10.1093/cid/civ561. Epub 2015 Jul 14. Clin Infect Dis. 2015. PMID: 26175520
-
Maternal Immunity and the Natural History of Congenital Human Cytomegalovirus Infection.Viruses. 2018 Aug 3;10(8):405. doi: 10.3390/v10080405. Viruses. 2018. PMID: 30081449 Free PMC article. Review.
-
Maternal immune correlates of protection against placental transmission of cytomegalovirus.Placenta. 2017 Dec;60 Suppl 1(Suppl 1):S73-S79. doi: 10.1016/j.placenta.2017.04.011. Epub 2017 Apr 20. Placenta. 2017. PMID: 28456432 Free PMC article. Review.
Cited by
-
The immunological underpinnings of vaccinations to prevent cytomegalovirus disease.Cell Mol Immunol. 2015 Mar;12(2):170-9. doi: 10.1038/cmi.2014.120. Epub 2014 Dec 29. Cell Mol Immunol. 2015. PMID: 25544503 Free PMC article. Review.
-
Neutralizing Monoclonal Antibodies Reduce Human Cytomegalovirus Infection and Spread in Developing Placentas.Vaccines (Basel). 2019 Sep 29;7(4):135. doi: 10.3390/vaccines7040135. Vaccines (Basel). 2019. PMID: 31569508 Free PMC article.
-
Systemic priming-boosting immunization with a trivalent plasmid DNA and inactivated murine cytomegalovirus (MCMV) vaccine provides long-term protection against viral replication following systemic or mucosal MCMV challenge.J Virol. 2005 Jan;79(1):159-75. doi: 10.1128/JVI.79.1.159-175.2005. J Virol. 2005. PMID: 15596812 Free PMC article.
-
A spread-deficient cytomegalovirus for assessment of first-target cells in vaccination.J Virol. 2010 Aug;84(15):7730-42. doi: 10.1128/JVI.02696-09. Epub 2010 May 12. J Virol. 2010. PMID: 20463067 Free PMC article.
-
National serosurvey of cytomegalovirus in Australia.Clin Vaccine Immunol. 2006 Nov;13(11):1181-4. doi: 10.1128/CVI.00203-06. Epub 2006 Sep 6. Clin Vaccine Immunol. 2006. PMID: 16957061 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical